Proteomic phenotyping: metastatic and invasive breast cancer

Cancer Lett. 2004 Jul 16;210(2):245-53. doi: 10.1016/j.canlet.2004.01.019.

Abstract

The adriamycin resistant breast cancer cell line (MCF-7/ADR) is a subject of ongoing debate concerning its origin and or source. Previous studies in our laboratory showed that MCF-7/ADR has a unique cytosolic protein expression pattern when compared to that of the parental MCF-7 cell line and other drug resistant MCF-7 cell lines. Protein expression patterns obtained using two-dimensional gel electrophoresis and mass spectrometry indicated that this MCF-7/ADR cell line shares some similarities with the metastatic breast cancer cell lines MDA-MB. Further comparisons with available two-dimensional gel electrophoresis maps in the literature indicate that MCF-7/ADR has a protein expression signature even closer to of the ductal infiltrating breast carcinoma cell line 8701. These observations suggest that MCF-7/ADR cells might have originated in a selection of ductal infiltrating carcinoma cells, which were present among the original MCF-7 cell population. These ductal infiltrating carcinoma cells may possess an intrinsic adriamycin resistance phenotype.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal / genetics*
  • Carcinoma, Ductal / pathology*
  • Doxorubicin / pharmacology*
  • Drug Resistance, Neoplasm / genetics
  • Electrophoresis, Gel, Two-Dimensional
  • Female
  • Humans
  • Neoplasm Invasiveness*
  • Neoplasm Metastasis*
  • Phenotype
  • Proteomics*
  • Tumor Cells, Cultured

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin